Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry
A. De Soyza (Newcastle upon Tyne, United Kingdom), J. Chalmers (Dundee, United Kingdom), D. K (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), F. Blasi (Milano, Italy), F. Ringshausen (Hannover, Germany), M. Vendrell (Girona, Spain), P. Goeminne (Leuven, Belgium), W. Boersma (MCA.NL, Netherlands), A. Torres (Bacelona, Republic of Korea), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), C. Haworth (Cambs, United Kingdom), M. Murris (Toulouse, France), E. Polverino (Barcelona, Spain), S. Aliberti (Milano, Italy)
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. De Soyza (Newcastle upon Tyne, United Kingdom), J. Chalmers (Dundee, United Kingdom), D. K (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), F. Blasi (Milano, Italy), F. Ringshausen (Hannover, Germany), M. Vendrell (Girona, Spain), P. Goeminne (Leuven, Belgium), W. Boersma (MCA.NL, Netherlands), A. Torres (Bacelona, Republic of Korea), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), C. Haworth (Cambs, United Kingdom), M. Murris (Toulouse, France), E. Polverino (Barcelona, Spain), S. Aliberti (Milano, Italy). Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry. 2678
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: